Probiotic Supplementation May Improve Gingival Health and Modulate Oral Microbiota

What's new

A new study investigated the effectiveness of a specific probiotic, Weissella cibaria CMU (OraCMU), in managing gingivitis and early periodontitis. The findings indicate that daily supplementation with OraCMU for eight weeks led to notable improvements in gingival health, including reduced inflammation and bleeding, compared to a placebo group [1]. The research also observed beneficial changes in the oral microbiome and a decrease in inflammatory markers, suggesting a multi-faceted approach to oral health improvement [1].

The science behind it

Periodontal disease, which includes gingivitis and periodontitis, arises from an imbalance in oral bacteria (dysbiotic oral biofilms) and the body's subsequent inflammatory response [1]. Current treatments often have limitations, prompting interest in alternative or complementary therapies like probiotics. This study enrolled 80 participants and randomly assigned them to receive either OraCMU tablets or a placebo twice daily for eight weeks [1].

Researchers measured several clinical outcomes, including the gingival index (GI), bleeding on probing (BOP), probing depth, clinical attachment level, and plaque index. They also analyzed inflammation-related proteins and the composition of the oral microbiota [1].

The results showed that the probiotic group experienced significantly greater reductions in both GI and BOP compared to the placebo group by the end of the eight-week period [1]. Specifically, the GI decreased by an average of 0.19 in the probiotic group versus 0.08 in the placebo group, and BOP decreased by 7.74% in the probiotic group compared to 2.82% in the placebo group [1].

Furthermore, the study identified a significant decrease in inflammatory markers such as fibroblast growth factor-5, thymic stromal lymphopoietin, and the receptor activator of nuclear factor κB ligand/osteoprotegerin ratio in those taking the probiotic [1]. From a microbiological perspective, the levels of harmful bacteria like Porphyromonas gingivalis, Treponema denticola, and Prevotella intermedia were significantly reduced, while the beneficial Weissella bacteria increased in the probiotic group [1]. No serious adverse events were reported, indicating the probiotic's safety [1].

What it means in practice

For individuals experiencing gingivitis or early stages of periodontitis, incorporating Weissella cibaria CMU (OraCMU) as a daily supplement could offer a promising adjunctive therapy to traditional oral hygiene practices [1]. The observed improvements in gingival inflammation and bleeding, coupled with the modulation of the oral microbiome, suggest that this probiotic could help restore a healthier balance in the mouth [1]. This approach might be particularly appealing for those looking for non-invasive ways to support their oral health and reduce reliance on more intensive treatments.

Regular use of OraCMU could contribute to a reduction in key pathogenic bacteria associated with periodontal disease, while simultaneously boosting beneficial bacteria and dampening the inflammatory response [1]. This could lead to a more stable and resilient oral environment, potentially preventing the progression of gingivitis to more severe forms of periodontal disease.

Caveats

While the findings are encouraging, it is important to note that this was a single study, and further research with larger cohorts and longer follow-up periods would strengthen the evidence [1]. The study focused on individuals with gingivitis and incipient periodontitis, so the efficacy of OraCMU in more advanced stages of periodontal disease is not yet established [1]. Additionally, while no serious adverse events were reported, individual responses to probiotics can vary [1]. It is always advisable to consult with a dental professional before incorporating new supplements into an oral health regimen, especially for those with existing medical conditions or who are taking other medications.

Source: [1] https://pubmed.ncbi.nlm.nih.gov/41817287/